China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.3 CNY -2.43% Market Closed
Market Cap: 15.8B CNY
Have any thoughts about
China Resources Boya Bio pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 33.57 CNY. Compared to the current market price of 31.3 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
33.57 CNY
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
China Resources Boya Bio pharmaceutical Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for China Resources Boya Bio pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about China Resources Boya Bio pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about China Resources Boya Bio pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of China Resources Boya Bio pharmaceutical Group Co Ltd.

What unique competitive advantages
does China Resources Boya Bio pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does China Resources Boya Bio pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/S
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/E
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/OCF
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/FCFE
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/B
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/S
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/GP
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/EBIT
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/OCF
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/FCFF
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide EV/IC
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Show me price targets
for China Resources Boya Bio pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for China Resources Boya Bio pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for China Resources Boya Bio pharmaceutical Group Co Ltd?

What are the Net Income projections
for China Resources Boya Bio pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for China Resources Boya Bio pharmaceutical Group Co Ltd?

What are the EPS projections
for China Resources Boya Bio pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for China Resources Boya Bio pharmaceutical Group Co Ltd?

What are the EBIT projections
for China Resources Boya Bio pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for China Resources Boya Bio pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for China Resources Boya Bio pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of China Resources Boya Bio pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of China Resources Boya Bio pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of China Resources Boya Bio pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of China Resources Boya Bio pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing China Resources Boya Bio pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of China Resources Boya Bio pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide ROE
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide ROA
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide ROIC
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide ROCE
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Gross Margin
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Operating Margin
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Net Margin
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide FCF Margin
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Show all solvency ratios
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide D/E Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide D/A Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Quick Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Current Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide Cash Ratio
for China Resources Boya Bio pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for China Resources Boya Bio pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for China Resources Boya Bio pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of China Resources Boya Bio pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for China Resources Boya Bio pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China Resources Boya Bio pharmaceutical Group Co Ltd

Current Assets 6.6B
Cash & Short-Term Investments 5.5B
Receivables 571.8m
Other Current Assets 584.9m
Non-Current Assets 1.4B
Long-Term Investments 194.9m
PP&E 699.2m
Intangibles 401m
Other Non-Current Assets 81.5m
Current Liabilities 508.3m
Accounts Payable 70.8m
Accrued Liabilities 87.9m
Short-Term Debt 67.7m
Other Current Liabilities 281.9m
Non-Current Liabilities 30.6m
Long-Term Debt 3.9m
Other Non-Current Liabilities 26.7m
Efficiency

Earnings Waterfall
China Resources Boya Bio pharmaceutical Group Co Ltd

Revenue
2B CNY
Cost of Revenue
-793.5m CNY
Gross Profit
1.2B CNY
Operating Expenses
-998.9m CNY
Operating Income
214.4m CNY
Other Expenses
13.1m CNY
Net Income
227.5m CNY

Free Cash Flow Analysis
China Resources Boya Bio pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 37.7 CNY with a low forecast of 34.13 CNY and a high forecast of 42.74 CNY.

Lowest
Price Target
34.13 CNY
9% Upside
Average
Price Target
37.7 CNY
20% Upside
Highest
Price Target
42.74 CNY
37% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for China Resources Boya Bio pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Resources Boya Bio pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd

Country

China

Industry

Biotechnology

Market Cap

15.8B CNY

Dividend Yield

1.47%

Description

Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. The company is headquartered in Fuzhou, Jiangxi and currently employs 1,652 full-time employees. The company went IPO on 2012-03-08. The firm's main products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human immune globulin, hydrophobia human immune globulin, human fibrinogen, metformin hydrochloride, calcium dobesilate capsules, glimepiride and pioglitazone hydrochloride dispersible tablets, among others. The firm's blood products are mainly used in the treatment of tumor, liver diseases and diabetes, among others. The firm also provides diabetic pharmaceuticals and biochemical pharmaceuticals. The firm distributes its products mainly in domestic market.

Contact

JIANGXI
Fuzhou
No. 333, Huiquan Road, High-tech Industrial Development Zone
+867948264398
www.china-boya.com

IPO

2012-03-08

Employees

1 652

Officers

President & Director
Mr. Xiaoming Liang
VP, CFO, Secretary & Director
Mr. Huacheng Liang
Vice President
Mr. Shuanhong Zhang

See Also

Discover More
What is the Intrinsic Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock?

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 33.57 CNY.

Is China Resources Boya Bio pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 31.3 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 7%.

Back to Top